|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cyber-physical-social System in Intelligent Transportation显示文摘A cyber-physical system(CPS) is composed of a physical system and its corresponding cyber systems that are tightly fused at all scales and levels.CPS is helpful to improve the controllability,efficiency and reliability of a physical system,such as vehicle collision avoidance and zero-net energy buildings systems.It has become a hot R&D and practical area from US to EU and other countries.In fact,most of physical systems and their cyber systems are designed,built and used by human beings in the social and natural environments.So,social systems must be of the same importance as their CPSs.The indivisible cyber,physical and social parts constitute the cyber-physical-social system(CPSS),a typical complex system and it’s a challengeable problem to control and manage it under traditional theories and methods.An artificial systems,computational experiments and parallel execution(ACP) methodology is introduced based on which data-driven models are applied to social system.Artificial systems,i.e.,cyber systems,are applied for the equivalent description of physical-social system(PSS).Computational experiments are applied for control plan validation.And parallel execution finally realizes the stepwise control and management of CPSS.Finally,a CPSS-based intelligent transportation system(ITS) is discussed as a case study,and its architecture,three parts,and application are described in detail. | Gang Xiong Fenghua Zhu Xiwei Liu Xisong Dong Wuling Huang Songhang Chen Kai Zhao | 2015 | IEEE/CAA Journal of Automatica Sinica2015，2，3： | 8 |
| 2 | Vacuum laser cladding and effect of Hf on the cracking susceptibility and the microstructure of Fe-Cr-Ni laser-clad layer显示文摘 | Song Wuling Echigoya J Zhu Beidi | 2000 | Surface and Coatings Technology2000，126，1： | 1 |
| 3 | 胃癌组织中HER2基因扩增与蛋白表达的研究(英文)显示文摘Objective: The aim of the study was to investigate the human epidermal growth factor receptor 2(HER2) gene amplification and protein expression and interpretation points in the stomach mixed carcinomas. Methods: Immunohistochemistry(IHC) and fluorescence in situ hybridization(FISH) technique were used to detect HER2 gene amplification and expression of HER2 protein in 442 cases of gastric mixed carcinoma. Results: The expression rate of HER2 protein was 41.2%(182/442): the HER2 protein expression IHC 3+ extensive type in 18 cases, partial type in 21 cases, focal type in 8 cases, accounting for 10.6%(47/442); the HER2 protein expression IHC 2+ extensive type in 23 cases, partial type in 28 cases, focal type in 11 cases, accounting for 14.0%(62/442); the HER2 protein expression IHC 1+ extensive type in 27 cases, partial type in 31 cases, focal type in 15 cases, accounting for 16.5%(73/442). HER2 gene amplification rate of 442 cases was 16.1%(71/442). In 182 cases of HER2 protein positive expression, the HER2 gene cluster amplification rate was 14.8%(27/182), large granular amplification rate 11.0%(20/182), punctate amplification rate 6.0%(11/182) and high polysomy 7.1%(13/182). In 71 cases of HER2 gene amplification, there was 42 cases of HER2 protein expression IHC 3+, 22 cases of HER2 protein expression IHC 2+, and 7 cases of IHC 1+. Conclusion: HER2 detection of gastric mixed carcinoma has great heterogeneity, HER2 protein positive expression is divided into extensive type, partial type and focal type, and HER2 gene positive amplification is divided into cluster amplification, large granular amplification, punctate amplification and high polysomy. These typing of HER2 protein expression and HER2 gene amplification provide reference index to quantify for targeted therapeutic effect of anticancer drugs. | Sunan Wang Yingying Li Zhengshun Xu Wenzhao Zhao Tian Yun Wuling Zhu Yangkun Wang | 2014 | The Chinese-German Journal of Clinical Oncology2014，13，6： | 0 |
| 4 | Clinical and Pathological Observation on Infectious Serositis of Duck显示文摘According to clinical and pathological observation in infectious serositis of duck, the main signs of this disease were diarrhoea, breathing with difficulty, head tremble and movement beyond coordination. The pathological changes that had been found in 30 experimental ducks were fibrous pericarditis, hepatitis, and encephalitis. The fibrous serositis, liver fatty degeneration or focus necrosis,nonsuppurative encephalitis and serous-fibrous pneumonia were typical pathological changes of histology. | Den Zhibang , Yang Lijun , and Zhu Shenghai Wuling University, Zhangjiajie 427000, China | 2002 | Hunan Agricultural Science & Technology Newsletter2002，3，2： | 0 |
| 5 | In Vitro Nanobody Library Construction by Using Gene Designated-Region Pan-Editing Technology显示文摘Camelid single-domain antibody fragments(nanobodies)are an emerging force in therapeutic biopharmaceuticals and clinical diagnostic reagents in recent years.Nearly all nanobodies available to date have been obtained by animal immunization,a bottleneck restricting the large-scale application of nanobodies.In this study,we developed three kinds of gene designatedregion pan-editing(GDP)technologies to introduce multiple mutations in complementarity-determining regions(CDRs)of nanobodies in vitro.Including the integration of G-quadruplex fragments in CDRs,which induces the spontaneous multiple mutations in CDRs;however,these mutant sequences are highly similar,resulting in a lack of sequences diversity in the CDRs.We also used CDR-targeting traditional gRNA-guided base-editors,which effectively diversify the CDRs.And most importantly,we developed the self-assembling gRNAs,which are generated by reprogrammed tracrRNA hijacking of endogenous mRNAs as crRNAs.Using base-editors guided by self-assembling gRNAs,we can realize the iteratively diversify the CDRs.And we believe the last GDP technology is highly promising in immunization-free nanobody library construction,and the full development of this novel nanobody discovery platform can realize the synthetic evolution of nanobodies in vitro. | Zhiyuan Niu Zhixia Luo Pengyang Sun Linwei Ning Xinru Jin Guanxu Chen Changjiang Guo Lingtong Zhi Wei Chang Wuling Zhu | 2022 | BioDesign Research2022，，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员